Cytomegalovirus-specific CD154-expressing T Cells are Present Before Transplantation in Cytomegalovirus-seronegative Recipients and Predict Early Cytomegalovirus DNAemia

Background. Cytomegalovirus (CMV) antiviral drugs can cause side effects and promote the emergence of drug-resistance after transplantation. T cell–mediated immunity to CMV (CMI) can be used to limit and optimize the duration of antiviral therapy. However, interferon-gamma release assays show varyin...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lisa Remaley, PAC, Kyle Soltys, MD, Tamara Fazzolare, PAC, Mylarappa Ningappa, PhD, Michael Green, MD, Marian Michaels, MD, Morgan Paul, BS, Brianna Spishock, BS, Dawn Wilkerson, MSN, Vikram Raghu, MD, Brandon W Higgs, PhD, George Mazariegos, MD, Ajay Khanna, MD, Armando Ganoza, MD, Geoffrey Bond, MD, Chethan Ashokkumar, PhD, Rakesh Sindhi, MD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer 2026-03-01
coleção:	Transplantation Direct
Acesso em linha:	http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001923
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!